Search Results 1141-1150 of 18265 for Topical

1. Clinical trials - Oncology (Medical)

   Dietary and Topical Magnesium Replacement or Supplementation in Patients with Lymphoma. Rochester, Minn. The purpose of this research study is to find out if ...

2. A Study to Evaluate the Effectiveness of Antihistamines in the Treatment of Eosinophilic Esophagitis - Mayo Clinic

   Patients who have used topical or systemic corticosteroid therapy for any reason in the previous 6 weeks. Patients who have been treated with acid ...

3. Publications - Nahid Y. Vidal, M.D. - Mayo Clinic

   Dramatic saxophone penis as a result of topical imiquimod use. JAMA Dermatol. 2014 Dec; 150 (12):1370-1. View PubMed. PST-20492609. Home; Publications. Fuel ...

4. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   Subject who received nonsteroidal anti-inflammatory drugs (NSAIDs) within 7 days prior to Baseline, except topical NSAIDs and low dose aspirin for ...

5. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

   *Allowed: Nasal, topical steroids, oral budesonide, ophthalmic. Subject must not have had a recent (within 1 week of the elevated index lab) intra-articular ...

6. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

   Use of topical (rectal) aminosalicylic acid (eg, mesalamine) or topical (rectal) steroids within 2 weeks prior to baseline; Use of intravenous or ...

7. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

   Topical steroid creams for symptomatic relief for patients in Cohort C (TMF) are exceptions to this rule. Also, the use of physiologic doses of ...

8. A Study to Evaluate AFPᶜ³³²T in Advanced HCC - Mayo Clinic

   NOTE: Use of inhaled or topical steroids is not exclusionary. Sorafenib/Regorafenib/Lenvatinib within 1 week;; Cabozantinib within 2 weeks;; Duration of ...

9. Progel Vascular Sealant - Clinical Trials

   Following this injection, subject has a leaking site where a topical sealant/hemostatic agent may be used to control bleeding. Exclusion Criteria: Subject ...

10. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

    Inhaled and topical corticosteroids are permitted. Refer to Appendix C for a corticosteroid dose conversion table. Women of childbearing potential (WOCBP) ...